Clinical Trials
3 trialsNCT04379596 2026-05-13
DG-03
AstraZeneca
Phase 2 Recruiting
NCT05480384 2026-04-21
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
Brown University
Phase 2 Active not recruiting
NCT05965479 2024-11-12
DECIPHER
University of Southampton
Phase 2 Recruiting